T1-116C

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameT1-116C
Drug Alias NameT-1-116-CT1-116C
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor protein p53 stimulants
TargetsTumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oxford
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Oxford
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A